Literature DB >> 3758820

Histological and histochemical changes in the columnar lined (Barrett's) oesophagus.

G A Rothery, J E Patterson, C J Stoddard, D W Day.   

Abstract

Multiple endoscopic specimens were obtained from 58 patients with a columnar lined gesophagus to study the histological and histochemical features of this metaplastic epithelium. Five patients (8.6%) had presented with a primary oesophageal adenocarcinoma. Three different epithelial types, junctional, atrophic fundic and intestinal were identified. Twenty two (38%) patients had just one type of epithelium present, the other 36 (62%) having a combination of two or three different types. Intestinal type of epithelium, either alone or in combination with gastric type epithelium was present in 48 (83%) patients. In every case this intestinal type epithelium took the form of an incompletely differentiated variant of intestinal metaplasia, although complete intestinal metaplasia as a focal change was also present in 14 of these patients. Histochemically, sulphomucins were present in the biopsies of 43 (74%) of the patients studied. They were seen in both goblet and columnar mucous cells with almost equal frequency. Incomplete intestinal metaplasia with sulphomucin production was present in four of the five patients with an oesophageal adenocarcinoma. In the columnar lined oesophagus sulphomucin production is common and its presence does not help to identify those individuals at particular risk of developing an adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3758820      PMCID: PMC1433804          DOI: 10.1136/gut.27.9.1062

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  34 in total

1.  DIAMINE METHODS FOR DIFFERENTIALING MUCOSUBSTANCES HISTOCHEMICALLY.

Authors:  S S SPICER
Journal:  J Histochem Cytochem       Date:  1965-03       Impact factor: 2.479

2.  Barrett syndrome. Case report with discussion about concepts of pathogenesis.

Authors:  M C GOLDMAN; R C BECKMAN
Journal:  Gastroenterology       Date:  1960-07       Impact factor: 22.682

3.  The histologic spectrum of Barrett's esophagus.

Authors:  A Paull; J S Trier; M D Dalton; R C Camp; P Loeb; R K Goyal
Journal:  N Engl J Med       Date:  1976-08-26       Impact factor: 91.245

4.  Enzyme and ultrastructural characteristics of esophageal columnar epithelium.

Authors:  M M Berenson; J J Herbst; J W Freston
Journal:  Am J Dig Dis       Date:  1974-10

5.  Morphology of the epithelium of the distal esophagus in patients with midesophageal peptic strictures.

Authors:  J S Trier
Journal:  Gastroenterology       Date:  1970-04       Impact factor: 22.682

6.  Multiple adenomatous neoplasms arising in columnarlined (Barrett's) esophagus.

Authors:  G B McDonald; D L Brand; D R Thorning
Journal:  Gastroenterology       Date:  1977-06       Impact factor: 22.682

7.  Morphological characteristics of the columnar epithelium lining the lower oesophagus in patients with Barrett's syndrome.

Authors:  E Hage; S A Pedersen
Journal:  Virchows Arch A Pathol Pathol Anat       Date:  1972

8.  The columnar-lined esophagus (Barrett syndrome)--an acquired condition?

Authors:  S M Mossberg
Journal:  Gastroenterology       Date:  1966-05       Impact factor: 22.682

9.  Regnerative of cardiac type mucosa and acquisition of Barrett mucosa after esophagogastrostomy.

Authors:  S R Hamilton; J H Yardley
Journal:  Gastroenterology       Date:  1977-04       Impact factor: 22.682

10.  Columnar-lined lower esophagus: an acquired lesion with malignant predisposition. Report on 140 cases of Barrett's esophagus with 12 adenocarcinomas.

Authors:  A P Naef; M Savary; L Ozzello
Journal:  J Thorac Cardiovasc Surg       Date:  1975-11       Impact factor: 5.209

View more
  20 in total

1.  Esophageal histology does not provide additional useful information over clinical assessment in identifying reflux patients presenting for esophagogastroduodenoscopy.

Authors:  S Nandurkar; N J Talley; C J Martin; T Ng; S Adams
Journal:  Dig Dis Sci       Date:  2000-02       Impact factor: 3.199

Review 2.  Barrett's oesophagus--to screen or not to screen?

Authors:  M Atkinson
Journal:  Gut       Date:  1989-01       Impact factor: 23.059

3.  Further studies on Barretts mucosa in baboons: metaplastic glandular cells produce sialomucin.

Authors:  Carlos A Rubio; Michael Owston; Abiel Orrego; Edward J Dick
Journal:  Anticancer Res       Date:  2010-10       Impact factor: 2.480

Review 4.  Barrett's oesophagus: from metaplasia to dysplasia and cancer.

Authors:  J-F Fléjou
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

5.  Dynamic effects of acid on Barrett's esophagus. An ex vivo proliferation and differentiation model.

Authors:  R C Fitzgerald; M B Omary; G Triadafilopoulos
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

6.  Barrett's esophagus. Correlation between mucin histochemistry, flow cytometry, and histologic diagnosis for predicting increased cancer risk.

Authors:  R C Haggitt; B J Reid; P S Rabinovitch; C E Rubin
Journal:  Am J Pathol       Date:  1988-04       Impact factor: 4.307

7.  A mixed pattern of endocrine cells in metaplastic Barrett's oesophagus. Evidence that the epithelium derives from a pluripotential stem cell.

Authors:  G Rindi; A E Bishop; M J Daly; P Isaacs; F I Lee; J M Polak
Journal:  Histochemistry       Date:  1987

8.  The length of the Barrett's mucosa in baboons, revisited.

Authors:  Carlos A Rubio; John R Nilsson; Michael Owston; Edward J Dick
Journal:  Anticancer Res       Date:  2012-08       Impact factor: 2.480

9.  Distinct immunohistochemical findings in columnar epithelium of esophageal inlet patch and of Barrett's esophagus.

Authors:  G E Feurle; V Helmstaedter; A Buehring; U Bettendorf; V F Eckardt
Journal:  Dig Dis Sci       Date:  1990-01       Impact factor: 3.199

Review 10.  Barrett's esophagus: histopathologic definitions and diagnostic criteria.

Authors:  James Mueller; Martin Werner; Manfred Stolte
Journal:  World J Surg       Date:  2004-01-20       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.